Back

PHOSPHO1, a novel skeletal regulator of insulin resistance and obesity

Suchacki, K. J.; Morton, N. M.; Vary, C.; Huesa, C.; Yadav, M. C.; Thomas, B. J.; Rajoanah, S.; Bunger, L.; Ball, D.; Barrios-Llerena, M.; Guntur, A. R.; Khavandgar, Z.; Cawthorn, W. P.; Ferron, M.; Karsenty, G.; Murshed, M.; Rosen, C. J.; MacRae, V. E.; Millan, J. L.; Farquharson, C.

2020-05-05 physiology
10.1101/2020.05.04.075895 bioRxiv
Show abstract

The skeleton is recognised as a key endocrine regulator of metabolism. Here we show that mice lacking the bone mineralization enzyme PHOSPHO1 (Phospho1-/-) exhibited improved basal glucose homeostasis and resisted high-fat-diet induced weight gain and diabetes. The metabolic protection in Phospho1-/- mice was manifested in the absence of altered levels of osteocalcin. Osteoblasts isolated from Phospho1-/- mice were enriched for genes associated with energy metabolism and diabetes; Phospho1 both directly and indirectly interacted with genes associated with glucose transport and insulin receptor signalling. Canonical thermogenesis via brown adipose tissue did not underlie the metabolic protection observed in adult Phospho1-/- mice. However, the decreased serum choline levels in Phospho1-/- mice were normalized by feeding a 2% choline rich diet resulting in a normalization in insulin sensitivity and fat mass. This study identifies PHOSPHO1 as a potential therapeutic target for the treatment of obesity and diabetes.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.